Esmolol Amomed is indicated for supraventricular tachycardia (except for preexcitation syndromes) and when rapid of increased ventricular rate in patients with patients with atrial fibrillation or atrial flutter perioperatively, or under other conditions and short duration control of ventricular rate with a short-acting substance is appropriate.
Esmolol Amomed may also be given for tachycardia and hypertension in the perioperative period and for non-compensatory sinus tachycardia.
Sinus tachycardia if, in the judgement of the treating physician, there is a particular need for treatment.
Esmolol Amomed is not suitable for the treatment of chronic diseases.
Active substance: Esmolol | Pharmaceutical form: Infusion solution, powder for the preparation of an infusion solution | Strength: 100 mg/10 ml (infusion solution), 2500 mg (powder)
Marketing authorisation holder: Amomed Pharma GmbH